nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-tRNA synthetase syndrome interstitial lung disease: A single center experience
|
Wilfong, Erin M. |
|
|
191 |
C |
p. |
artikel |
2 |
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)
|
Obi, Ogugua Ndili |
|
|
191 |
C |
p. |
artikel |
3 |
A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma
|
Czira, Alexandrosz |
|
|
191 |
C |
p. |
artikel |
4 |
Atopic diseases and airway-related symptoms in Bavarian children before starting primary school: Time trend analyses
|
Pirner, Christina |
|
|
191 |
C |
p. |
artikel |
5 |
Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia
|
Sheikh, Daniya |
|
|
191 |
C |
p. |
artikel |
6 |
Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020]
|
Martin, Neil |
|
|
191 |
C |
p. |
artikel |
7 |
Community-acquired pneumonia in infants: Not simply an acute event with complete recovery
|
Lapidot, Rotem |
|
|
191 |
C |
p. |
artikel |
8 |
Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature
|
Monteiro, Constança |
|
|
191 |
C |
p. |
artikel |
9 |
Differences in disease presentation between men and women with sarcoidosis: A cohort study
|
Lundkvist, Amanda |
|
|
191 |
C |
p. |
artikel |
10 |
Differential serum lipid distribution in IPAH and CHD-PAH patients
|
Chen, Jingyuan |
|
|
191 |
C |
p. |
artikel |
11 |
Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic
|
Berghaus, Thomas M. |
|
|
191 |
C |
p. |
artikel |
12 |
Diurnal variation in DLCO and non-standardized study procedures may cause a false positive safety signal in clinical trials
|
Kirla, Krishna Tulasi |
|
|
191 |
C |
p. |
artikel |
13 |
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study
|
Adams, Colin J. |
|
|
191 |
C |
p. |
artikel |
14 |
In-line treatments and clinical initiatives to fight against COVID-19 outbreak
|
Agrawal, Mukta |
|
|
191 |
C |
p. |
artikel |
15 |
Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options
|
Mohiuddin, Md |
|
|
191 |
C |
p. |
artikel |
16 |
Is it about what comes in or what goes out? A reply to Sesé et al., 2021
|
Saade, Anastasia |
|
|
191 |
C |
p. |
artikel |
17 |
Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease
|
Watanabe, Satoshi |
|
|
191 |
C |
p. |
artikel |
18 |
Letter to the Editor concerning A study on infectivity of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) carriers by Gao et al
|
Silverman, Erin P. |
|
|
191 |
C |
p. |
artikel |
19 |
Mortality outcomes associated with invasive aspergillosis among acute exacerbation of chronic obstructive pulmonary disease patient population
|
Mir, Tanveer |
|
|
191 |
C |
p. |
artikel |
20 |
Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma
|
Bourdin, Arnaud |
|
|
191 |
C |
p. |
artikel |
21 |
Occupation, socioeconomic status and chronic obstructive respiratory diseases – The EpiLung study in Finland, Estonia and Sweden
|
Jalasto, Juuso |
|
|
191 |
C |
p. |
artikel |
22 |
Optimizing the management of complicated pleural effusion: From intrapleural agents to surgery
|
Sorino, Claudio |
|
|
191 |
C |
p. |
artikel |
23 |
Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics
|
Kagohashi, Katsunori |
|
|
191 |
C |
p. |
artikel |
24 |
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma
|
Bateman, Eric D. |
|
|
191 |
C |
p. |
artikel |
25 |
Pleuroparenchymal fibroelastosis: Clinical, radiological and histopathological features
|
Ricoy, Jorge |
|
|
191 |
C |
p. |
artikel |
26 |
Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies
|
Flashner, Bess M. |
|
|
191 |
C |
p. |
artikel |
27 |
Respiratory muscle strength, exercise capacity and physical activity in patients with primary ciliary dyskinesia: A cross-sectional study
|
Firat, Merve |
|
|
191 |
C |
p. |
artikel |
28 |
Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)
|
Bateman, Eric D. |
|
|
191 |
C |
p. |
artikel |
29 |
Response to the correspondence: “Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma”
|
Bateman, Eric D. |
|
|
191 |
C |
p. |
artikel |
30 |
Sarcoidosis associated pleural effusion: Clinical aspects
|
Chopra, Amit |
|
|
191 |
C |
p. |
artikel |
31 |
Severe adverse events in children with tracheostomy and home mechanical ventilation - Comparison of pediatric home care and a specialized pediatric nursing care facility
|
Neunhoeffer, Felix |
|
|
191 |
C |
p. |
artikel |
32 |
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months
|
Steinbeis, Fridolin |
|
|
191 |
C |
p. |
artikel |
33 |
Sweat metabolomics before and after intravenous antibiotics for pulmonary exacerbation in people with cystic fibrosis
|
Woodley, Frederick W. |
|
|
191 |
C |
p. |
artikel |
34 |
The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF)
|
Bernardinello, Nicol |
|
|
191 |
C |
p. |
artikel |
35 |
Upper airway symptoms and Small Airways Disease in Chronic Obstructive Pulmonary Disease, COPD
|
Obling, Nicolai |
|
|
191 |
C |
p. |
artikel |
36 |
Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function
|
Tandon, Pranai |
|
|
191 |
C |
p. |
artikel |